SRRK Scholar Rock Holding Corp
Nasdaq · SEC CIK 1727196 · EDGAR
- Bought, last 12 months
- $19.99M 2 purchases by 1 insiders
- Sold, last 12 months
- $19.44M 26 sales by 13 insiders
- Filings on record
- 218 since 2021-07-28, latest 2026-09-23 16:36
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| AKKARAJU SRINIVAS | Dir | $19.99M | — |
| Qatanani Mo | CSO | — | $8.60M |
| Hallal David | CEO, Dir | — | $3.97M |
| Vaishnaw Akshay | Pres of R, D, Dir | — | $1.48M |
| Sinha Vikas | CFO | — | $1.23M |
| Woods Keith | COO | — | $1.22M |
| Ho Junlin | GC | — | $802.3K |
| Parlavecchio Caryn | CHRO | — | $714.0K |
| Marantz Jing L. | Chief Medical Off | — | $451.3K |
| Peng Katie | Dir | — | $337.8K |
Transactions 219
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-18 | SRRK | Ho Junlin | GC | S - Sale | $36.83 | -5,742 | 189.3K | -3% | -$211.5K | |
| 2025-02-20 | 2025-02-18 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $36.83 | -5,296 | 140.3K | -4% | -$195.1K | |
| 2025-01-21 | 2025-01-16 | SRRK | Backstrom Jay T. | CEO, Dir | S - Sale | $44.20 | -22.3K | 330.4K | -6% | -$986.0K | |
| 2025-01-21 | 2025-01-16 | SRRK | Sacco Tracey | Chief Commercial Off | S - Sale | $44.20 | -3,890 | 45.4K | -8% | -$171.9K | |
| 2025-01-21 | 2025-01-16 | SRRK | Qatanani Mo | CSO | S - Sale | $44.20 | -7,347 | 135.4K | -5% | -$324.7K | |
| 2025-01-21 | 2025-01-16 | SRRK | Ho Junlin | GC | S - Sale | $44.20 | -9,039 | 195.0K | -4% | -$399.5K | |
| 2025-01-21 | 2025-01-16 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $44.20 | -6,434 | 145.6K | -4% | -$284.4K | |
| 2025-01-21 | 2025-01-16 | SRRK | Myles Edward H | COO, CFO | S - Sale | $44.20 | -12.5K | 148.5K | -8% | -$554.2K | |
| 2025-01-21 | 2025-01-16 | SRRK | Marantz Jing L. | Chief MEDICAL Off | S - Sale | $44.20 | -5,655 | 67.2K | -8% | -$250.0K | |
| 2024-12-12 | 2024-12-10 | SRRK | Invus Global Management, LLC | 10% | S - Sale | $41.65 | -1.60M | 9.25M | -15% | -$66.64M | |
| M | 2024-11-27 | 2024-11-25 | SRRK | Invus Public Equities Advisors, LLC | 10% | S - Sale | $38.49 | -409.4K | 10.85M | -4% | -$15.76M |
| DM | 2024-11-26 | 2024-11-22+ | SRRK | Marantz Jing L. | Chief MEDICAL Off | S - Sale+OE | $37.06 | -8,520 | 72.9K | -10% | -$315.8K |
| DM | 2024-11-26 | 2024-11-22+ | SRRK | Marantz Jing L. | Chief MEDICAL Off | M - OptEx | $8.59 | +8,520 | 75.0K | +13% | +$73.2K |
| D | 2024-11-13 | 2024-11-11 | SRRK | Marantz Jing L. | Chief MEDICAL Off | M - OptEx | $8.59 | +2,105 | 75.0K | +3% | +$18.1K |
| D | 2024-11-13 | 2024-11-11 | SRRK | Marantz Jing L. | Chief MEDICAL Off | S - Sale+OE | $30.00 | -2,105 | 72.9K | -3% | -$63.1K |
| 2024-11-13 | 2024-11-12 | SRRK | Gilman Michael | Dir | G - Gift | — | +37.5K | 51.0K | +277% | — | |
| I | 2024-11-13 | 2024-11-12 | SRRK | Gilman Michael | Dir | G - Gift | — | -37.5K | 0 | -100% | — |
| D | 2024-10-10 | 2024-10-08 | SRRK | Myles Edward H | COO, CFO | S - Sale+OE | $34.90 | -37.2K | 161.1K | -19% | -$1.30M |
| D | 2024-10-10 | 2024-10-08 | SRRK | Myles Edward H | COO, CFO | M - OptEx | $10.00 | +37.2K | 198.3K | +23% | +$371.9K |
| D | 2024-10-07 | 2024-10-07 | SRRK | Sacco Tracey | Chief COMMERCIAL Off | M - OptEx | $10.00 | +30.0K | 79.3K | +61% | +$300.0K |
| DM | 2024-10-07 | 2024-10-07 | SRRK | Sacco Tracey | Chief COMMERCIAL Off | S - Sale+OE | $25.62 | -30.0K | 49.3K | -38% | -$768.7K |
| DM | 2024-10-07 | 2024-10-07 | SRRK | Marantz Jing L. | Chief MEDICAL Off | S - Sale+OE | $27.21 | -109.4K | 72.9K | -60% | -$2.98M |
| D | 2024-10-07 | 2024-10-07 | SRRK | Marantz Jing L. | Chief MEDICAL Off | M - OptEx | $8.59 | +109.4K | 182.2K | +150% | +$939.5K |
| DM | 2024-10-07 | 2024-10-07 | SRRK | Myles Edward H | COO, CFO | S - Sale+OE | $26.56 | -206.2K | 255.4K | -45% | -$5.48M |
| D | 2024-10-07 | 2024-10-07 | SRRK | Myles Edward H | COO, CFO | M - OptEx | $13.83 | -206.2K | 367.3K | -36% | -$2.85M |
| MI | 2024-10-07 | 2024-10-07 | SRRK | AKKARAJU SRINIVAS | Dir | S - Sale | $29.25 | -1.18M | 5.77M | -17% | -$34.39M |
| 2024-09-19 | 2024-09-16 | SRRK | Qatanani Mo | CSO | S - Sale | $8.58 | -1,936 | 142.8K | -1% | -$16.6K | |
| 2024-08-19 | 2024-08-16 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $9.33 | -1,451 | 152.0K | -0.9% | -$13.5K | |
| D | 2024-07-01 | 2024-06-27 | SRRK | AKKARAJU SRINIVAS | Dir | A - Grant | $0.00 | +13.5K | 13.5K | New | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Brudnick Richard | Dir | A - Grant | $0.00 | +13.5K | 13.5K | New | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Peng Katie | Dir | A - Grant | $0.00 | +4,500 | 31.3K | +17% | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Vaishnaw Akshay | Dir | A - Grant | $0.00 | +13.5K | 23.0K | +143% | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | FLIER JEFFREY S. | Dir | A - Grant | $0.00 | +13.5K | 22.5K | +150% | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Reed Joshua | Dir | A - Grant | $0.00 | +13.5K | 13.5K | New | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Gilman Michael | Dir | A - Grant | $0.00 | +13.5K | 13.5K | New | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Hallal David | Dir | A - Grant | $0.00 | +13.5K | 304.1K | +5% | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Burow Kristina | Dir | A - Grant | $0.00 | +13.5K | 18.8K | +253% | $0 |
| 2024-06-18 | 2024-06-17 | SRRK | Ho Junlin | GC | S - Sale | $8.98 | -4,695 | 204.1K | -2% | -$42.2K | |
| 2024-06-18 | 2024-06-17 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $8.98 | -4,305 | 153.4K | -3% | -$38.7K | |
| 2024-06-18 | 2024-06-17 | SRRK | Qatanani Mo | CSO | S - Sale | $8.99 | -2,315 | 144.7K | -2% | -$20.8K | |
| 2024-06-18 | 2024-06-17 | SRRK | Myles Edward H | COO, CFO | S - Sale | $8.98 | -9,458 | 201.5K | -4% | -$84.9K | |
| M | 2024-05-13 | 2024-05-09 | SRRK | Nashat Amir | Dir | J - Other | $0.00 | +13.1K | 38.6K | +51% | $0 |
| MI | 2024-05-13 | 2024-05-09 | SRRK | Nashat Amir | Dir | J - Other | $0.00 | -499.7K | 0 | -100% | $0 |
| D | 2024-04-11 | 2024-04-09 | SRRK | Peng Katie | Dir | A - Grant | $0.00 | +26.8K | 26.8K | New | $0 |
| 2024-02-21 | 2024-02-16 | SRRK | Myles Edward H | COO, CFO | S - Sale | $15.74 | -4,744 | 211.0K | -2% | -$74.7K | |
| 2024-02-20 | 2024-02-16 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $15.74 | -3,751 | 157.7K | -2% | -$59.0K | |
| 2024-02-20 | 2024-02-16 | SRRK | Ho Junlin | GC | S - Sale | $15.74 | -3,489 | 208.8K | -2% | -$54.9K | |
| 2024-02-20 | 2024-02-16 | SRRK | Backstrom Jay T. | CEO, Dir | S - Sale | $15.74 | -11.6K | 352.7K | -3% | -$182.8K | |
| 2024-02-20 | 2024-02-16 | SRRK | Qatanani Mo | CSO | S - Sale | $15.74 | -2,512 | 147.0K | -2% | -$39.5K | |
| D | 2024-02-13 | 2024-02-12 | SRRK | Qatanani Mo | CSO | A - Grant | $0.00 | +70.7K | 149.5K | +90% | $0 |
| D | 2024-02-13 | 2024-02-12 | SRRK | Sacco Tracey | Chief COMMERCIAL Off | A - Grant | $0.00 | +49.3K | 49.3K | New | $0 |
| D | 2024-02-13 | 2024-02-12 | SRRK | Backstrom Jay T. | CEO, Dir | A - Grant | $0.00 | +214.3K | 364.3K | +143% | $0 |
| D | 2024-02-13 | 2024-02-12 | SRRK | Marantz Jing L. | Chief MEDICAL Off | A - Grant | $0.00 | +72.9K | 72.9K | New | $0 |
| D | 2024-02-13 | 2024-02-12 | SRRK | Ho Junlin | GC | A - Grant | $0.00 | +57.9K | 212.3K | +37% | $0 |
| D | 2024-02-13 | 2024-02-12 | SRRK | Parlavecchio Caryn | CHRO | A - Grant | $0.00 | +47.1K | 161.5K | +41% | $0 |
| D | 2024-02-13 | 2024-02-12 | SRRK | Myles Edward H | COO, CFO | A - Grant | $0.00 | +53.6K | 215.7K | +33% | $0 |
| 2024-01-18 | 2024-01-16 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $15.93 | -2,849 | 114.3K | -2% | -$45.4K | |
| 2024-01-18 | 2024-01-16 | SRRK | Qatanani Mo | SVP AND HEAD OF RESEARCH | S - Sale | $15.93 | -2,002 | 78.8K | -2% | -$31.9K | |
| 2024-01-18 | 2024-01-16 | SRRK | Myles Edward H | COO, CFO | S - Sale | $15.93 | -6,634 | 162.2K | -4% | -$105.7K | |
| 2024-01-18 | 2024-01-16 | SRRK | Ho Junlin | GC | S - Sale | $15.93 | -4,186 | 154.4K | -3% | -$66.7K | |
| 2023-12-29 | 2023-12-27 | SRRK | Nashat Amir | Dir | G - Gift | $0.00 | -21.3K | 25.5K | -46% | $0 | |
| DM | 2023-12-29 | 2023-12-29 | SRRK | Myles Edward H | COO, CFO | S - Sale+OE | $18.84 | -12.5K | 169.1K | -7% | -$234.7K |
| D | 2023-12-29 | 2023-12-29 | SRRK | Myles Edward H | COO, CFO | M - OptEx | $4.86 | +12.5K | 181.2K | +7% | +$60.6K |
| I | 2023-12-26 | 2023-12-21 | SRRK | Burow Kristina | Dir | J - Other | $0.00 | -291.9K | 2.35M | -11% | $0 |
| 2023-12-26 | 2023-12-21 | SRRK | Burow Kristina | Dir | J - Other | $0.00 | +5,339 | 5,339 | New | $0 | |
| D | 2023-12-15 | 2023-12-14 | SRRK | Qatanani Mo | SVP AND HEAD OF RESEARCH | M - OptEx | $10.00 | +8,437 | 105.5K | +9% | +$84.4K |
| D | 2023-12-15 | 2023-12-14 | SRRK | Qatanani Mo | SVP AND HEAD OF RESEARCH | S - Sale+OE | $18.18 | -24.7K | 80.8K | -23% | -$448.4K |
| MI | 2023-12-15 | 2023-12-13 | SRRK | Nashat Amir | Dir | J - Other | $0.00 | -999.4K | 124.1K | -89% | $0 |
| M | 2023-12-15 | 2023-12-13 | SRRK | Nashat Amir | Dir | J - Other | $0.00 | +26.3K | 46.8K | +128% | $0 |
| D | 2023-12-08 | 2023-12-07 | SRRK | Myles Edward H | COO, CFO | M - OptEx | $4.86 | +24.9K | 193.7K | +15% | +$121.1K |
| D | 2023-12-08 | 2023-12-07 | SRRK | Myles Edward H | COO, CFO | S - Sale+OE | $17.53 | -24.9K | 168.8K | -13% | -$436.7K |
| MI | 2023-11-22 | 2023-11-20 | SRRK | Nashat Amir | Dir | J - Other | $0.00 | -499.7K | 0 | -100% | $0 |
| M | 2023-11-22 | 2023-11-20 | SRRK | Nashat Amir | Dir | J - Other | $0.00 | +13.1K | 20.5K | +177% | $0 |
| 2023-11-03 | 2023-11-02 | SRRK | Myles Edward H | COO, CFO | S - Sale | $12.51 | -35.0K | 168.8K | -17% | -$437.9K | |
| I | 2023-10-18 | 2023-10-16 | SRRK | AKKARAJU SRINIVAS | Dir, 10% | P - Purchase | $6.85 | +2.19M | 6.79M | +48% | +$15.00M |
| I | 2023-10-18 | 2023-10-16 | SRRK | Samsara BioCapital GP, LLC | 10% | P - Purchase | $6.85 | +2.19M | 6.79M | +48% | +$15.00M |
| M | 2023-10-16 | 2023-10-12 | SRRK | Wittouck Amaury | 10% | P - Purchase | $6.86 | +2.20M | 11.26M | +24% | +$15.09M |
| 2023-09-20 | 2023-09-18 | SRRK | Qatanani Mo | SVP AND HEAD OF RESEARCH | S - Sale | $6.34 | -1,945 | 97.0K | -2% | -$12.3K | |
| 2023-08-18 | 2023-08-16 | SRRK | Parlavecchio Caryn | CHRO | S - Sale | $6.83 | -1,353 | 117.2K | -1% | -$9,241 | |
| 2023-06-22 | 2023-06-21 | SRRK | Parlavecchio Caryn | CHRO | F - Tax | $8.75 | -4,038 | 118.6K | -3% | -$35.3K | |
| 2023-06-22 | 2023-06-21 | SRRK | Ho Junlin | GC | F - Tax | $8.75 | -4,346 | 158.6K | -3% | -$38.0K | |
| 2023-06-22 | 2023-06-21 | SRRK | Myles Edward H | COO, CFO | F - Tax | $8.75 | -7,138 | 203.8K | -3% | -$62.5K | |
| 2023-05-02 | 2023-04-28 | SRRK | Artal International Management S.A. | 10% | P - Purchase | $6.43 | +31.6K | 9.06M | +0.3% | +$202.9K | |
| D | 2023-02-15 | 2023-02-13 | SRRK | Ho Junlin | GC | A - Grant | $0.00 | +46.9K | 162.9K | +40% | $0 |
| D | 2023-02-15 | 2023-02-13 | SRRK | Backstrom Jay T. | CEO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
| D | 2023-02-15 | 2023-02-13 | SRRK | Myles Edward H | COO, CFO | A - Grant | $0.00 | +63.8K | 210.9K | +43% | $0 |
| D | 2023-02-15 | 2023-02-13 | SRRK | Parlavecchio Caryn | CHRO | A - Grant | $0.00 | +46.9K | 122.6K | +62% | $0 |
| 2023-01-19 | 2023-01-17 | SRRK | Parlavecchio Caryn | CHRO | F - Tax | $11.28 | -2,934 | 75.7K | -4% | -$33.1K | |
| 2023-01-19 | 2023-01-17 | SRRK | Ho Junlin | GC | F - Tax | $11.29 | -4,529 | 116.1K | -4% | -$51.1K | |
| 2023-01-19 | 2023-01-17 | SRRK | Myles Edward H | COO, CFO | F - Tax | $11.29 | -7,043 | 147.2K | -5% | -$79.5K | |
| 2023-01-11 | 2023-01-09 | SRRK | Artal Group S.A. | 10% | S - Sale | $9.48 | -1,094 | 9.03M | -0.0% | -$10.4K | |
| 2023-01-09 | 2023-01-05 | SRRK | Artal Group S.A. | 10% | P - Purchase | $9.33 | +48.8K | 9.03M | +0.5% | +$455.1K | |
| 2022-10-27 | 2022-10-25 | SRRK | Stichting Administratiekantoor Westend | 10% | P - Purchase | $8.04 | +130.3K | 8.98M | +1% | +$1.05M | |
| M | 2022-10-07 | 2022-10-03+ | SRRK | Invus Public Equities Advisors, LLC | 10% | P - Purchase | $7.60 | +100.0K | 8.78M | +1% | +$759.6K |
| 2022-08-17 | 2022-08-16 | SRRK | Parlavecchio Caryn | CHRO | F - Tax | $11.34 | -1,401 | 78.6K | -2% | -$15.9K | |
| I | 2022-07-12 | 2022-07-08 | SRRK | Gilman Michael | Dir | G - Gift | — | +37.5K | 37.5K | New | — |
| 2022-07-12 | 2022-07-08 | SRRK | Gilman Michael | Dir | G - Gift | — | -37.5K | 0 | -100% | — | |
| DMI | 2022-06-24 | 2022-06-22 | SRRK | Nashat Amir | Dir | P - Purchase | $4.90 | +1.20M | 206.9K | New | +$5.87M |
| D | 2022-06-21 | 2022-06-16 | SRRK | Mahanthappa Nagesh K. | Pres, Interim CEO | A - Grant | $0.00 | +50.0K | 480.5K | +12% | $0 |
| D | 2022-06-21 | 2022-06-16 | SRRK | Parlavecchio Caryn | CHRO | A - Grant | $0.00 | +35.8K | 80.0K | +81% | $0 |
Purchase Sale Sale after option exercise All abbreviations